Quantitative stock rating · as of 2026-11-05

Adma Biologics, Inc. (ADMA)

Name: Adma Biologics, Inc. (ADMA) Stock Rating: C (Hold)
Item: Adma Biologics, Inc.
Rating: C
Author: QuantHarbor

Hold

QuantHarbor five-lens rating band

Standout lens: Quality.
Main drag: Momentum.

Price at the rating date (2026-11-05): $10.48.

The rating grades ADMA through five lenses — Quality, Valuation, Momentum, Growth Trend and Price Stability — computed from filings and market data, refreshed nightly. When data is too thin to score a lens, we withhold it instead of guessing.

See the full ADMA teardown free

Lens scores, the valuation zone, financial statement charts and the complete methodology are available with a free account. QuantHarbor is descriptive research, not investment advice.